Subscribe to Newsletter

Mark Emalfarb

Mark Emalfarb is President and Chief Executive Officer, Dyadic International, Jupiter, FL, USA.

Content by Mark Emalfarb:

 Manufacture Biosimilars

The CHO’s Over: An Inflexion Point

| Mark Emalfarb

Global healthcare costs and demands are changing, and it’s time to look beyond mammalian cell lines.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

February Issue of The Medicine Maker